Publication | Closed Access

Can Tyrosine Kinase Inhibitors be Discontinued in Patients with Metastatic Renal Cell Carcinoma and a Complete Response to Treatment? A Multicentre, Retrospective Analysis

UrologyOncologyGenitourinary CancerMedicineKinase InhibitorsRetrospective AnalysisComplete ResponsePharmacotherapyCancer TreatmentPharmacology